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Abstract: Increasing production and application of nanomaterials raises significant questions 
regarding the potential for cellular entry and toxicity of nanoparticles. It was observed that the 
presence of serum reduces the cellular association of 20 nm carboxylate-modified fluorescent 
polystyrene beads up to 20-fold, relative to cells incubated in serum-free media. Analysis by 
confocal microscopy demonstrated that the presence of serum greatly reduces the cell surface 
association of nanoparticles, as well as the potential for internalization. However, both in the 
presence and absence of serum, nanoparticle entry depends upon clathrin-mediated   endocytosis. 
Finally, experiments performed with cells cooled to 4°C suggest that a proportion of the 
accumulation of nanoparticles in cells was likely due to direct permeabilization of the plasma 
membrane.
Keywords: nanoparticles, polystyrene beads, serum, endocytosis, dynamin, clathrin, 
permeabilization
Introduction
Nanoparticles are defined as structures with at least one dimension smaller than 
100 nm.1 Although humans have always come into contact with naturally occurring 
nanoparticles, the ever increasing production and application of manufactured nanopar-
ticles in industry, research, and medicine has led to greater potential for incidental envi-
ronmental contact, as well as deliberate exposure through products and therapeutics.2,3 
However, the potential for cellular entry and toxicity of manufactured nanoparticles has 
only recently begun to be investigated. The extent of potential cellular effects follow-
ing nanoparticle exposure can depend upon target cell type, environmental conditions, 
nanoparticle composition, size, shape, surface chemistry, and dosage.4
Given the potential for heterogeneity, when comparing different nanoparticles, cells, 
and experimental conditions, each particular system of interest must be empirically 
analyzed. Therefore, model nanoparticles with well-defined characteristics have been 
serving as a valuable tool in understanding the potential for intracellular exposure and 
cellular toxicity.5–9 Polystyrene nanoparticles can be generated (eg, FluoSpheres® from 
Invitrogen Life Technologies, Carlsbad, CA) within accurate size ranges, to a nearly 
uniform shape, and with a variety of surface coatings and fluorescent labels useful for 
tracking in biological systems. Already, numerous studies have been published analyz-
ing the entry of polystyrene nanoparticles into different types of cells; however, these 
reports have not been entirely consistent in the observations reported.5–9 In particular, 
size and surface characteristics have emerged as potentially important characteristics 
regulating the potential for cellular entry and the specific mechanisms involved.4–10
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One further factor which could affect the potential 
for cellular entry of nanoparticles is the generation of a 
“protein corona.”4 It has been determined that carboxylate 
modification of polystyrene nanoparticles can promote 
interactions with proteins,11 and reduced cell surface binding 
was observed for larger polystyrene particles (eg, ∼200 nm) 
incubated in the presence of serum.12 Therefore, studies were 
performed to assess potential serum-dependent effects on 
nanoparticle interactions with cells, and potential mecha-
nisms for nanoparticle internalization. Taken together, the 
results demonstrate a striking serum dependence for plasma 
membrane binding and subsequent nanoparticle entry into 
cells via clathrin-mediated endocytosis. Finally, these studies 
suggest that plasma membrane permeabilization is another 
potential mode of nanoparticle entry into cells. This is 
significant when considering other nanomaterials that are 
used for humans as this effect was seen both in the presence 
and absence of serum, suggesting this effect may be size 
dependent only.
Material and methods
Cell culture
HeLa and MDCK cell lines (Health Protection Agency 
  Culture Collections, Salisbury, United Kingdom) were grown 
at 37°C in the presence of 5% carbon dioxide with Gibco® 
Dulbecco’s modified Eagle medium (DMEM) (Invitrogen) 
supplemented with 10% fetal calf serum (Invitrogen), and 
1% penicillin/streptomycin (Invitrogen). Cells were detached 
with trypsin (Invitrogen) following Gibco phosphate buffered 
saline (PBS) wash (Invitrogen). Detached cells were trans-
ferred at appropriate dilutions into new flasks or plated onto 
24 mm glass coverslips in six-well plates for fixation. They 
were incubated in a CO2 ncubator (MCO-17AIC; SANYO, 
Osaka, Japan) at 37°C in the presence of 5% carbon dioxide 
for ∼24 hours prior to transfection (see below) or incubation 
in nanoparticles (see below).
Nanoparticle uptake experiments:  
plate reader
Cells were grown in µClear® black 96-well glass bottom 
plates (Greiner Bio-One GmbH, Frickenhausen,   Germany). 
Yellow/green and red 20 nm carboxylate-modified polystyrene 
  FluoSpheres (Invitrogen) (stock 0.02 g/mL ≡ 4.54 × 1015 nano-
particles/mL) were at a 1% dilution in either serum-containing 
or serum-free media and added to cells for 0, 5, 15, 30, 60, and 
120 minutes. After the allotted time, cells were rinsed twice 
with 100 µL PBS and incubated for 5 minutes in 100 µL of 4% 
paraformaldehyde (Electron Microscopy Sciences, Hatfield, 
PA) in PBS. They were then rinsed twice more with 100 µL 
PBS. The fluorescence was observed with PBS solution inside 
the wells with a FLUOStar Omega fluorescence plate reader 
(BMG LABTECH GmbH, Ortenberg, Germany).
Determination of size and zeta potential 
by dynamic and electrophoretic light 
scattering
Size (hydrodynamic diameter) and zeta potential measure-
ments of nanoparticle dispersion were done using a Zetasizer® 
Nano ZS ZEN3600 (Malvern Instruments Ltd, Malvern, 
United Kingdom) to investigate possible aggregation of 
nanoparticles. Nanoparticles were at 0.5% dilution from 
stock in each experimental variation and sonicated in 
ultrasonic bath (XUB18; Grant Instruments, Shepreth, UK) 
for 20 minutes before measurement.
Nanoparticle cytotoxicity experiments
Cells were grown on MatTek glass bottom plates (MatTek 
Corporation, Ashland, MA) for 24 hours in 2 mL serum-
containing media. The media was exchanged for one of 
the following: serum-containing media; serum-free media; 
serum-containing media with 1% nanoparticles from stock 
solution; or serum free media with 1% nanoparticles from 
stock solution for 15 minutes at 37°C. These were then 
replaced with serum-containing media and returned to the 
incubator for a further 24 or 72 hours. For counting, the 
cells were rinsed twice with 2 mL PBS and incubated in 
1 mL trypsin for 4 minutes. Cells were put into a Hawksley 
counting chamber (AS1000 Improved Neubauer Double 
Cell Standard; Hawksley, Sussex, United Kingdom) and 
counted.
Nanoparticle uptake experiments: 
microscopy
Cells were attached onto glass coverslips and incubated 
overnight. For the 4°C experiment, cells were put on ice for 
5 minutes in either serum-containing or serum-free media. 
Chilled green nanoparticles diluted to 1% in either serum-
containing or serum-free media were introduced to the 
cells for 15 minutes. For fixation, cells were rinsed in 2 mL 
chilled PBS twice and fixed with 1 mL 4% paraformaldehyde 
in PBS for 5 minutes. At this time the chilled cells were 
brought back to room temperature. They were then rinsed 
twice more with 2 mL PBS and then placed cells down on 
a coverslip with a small drop of Vectashield® containing 
4′,6-diamidino-2-phenylindole (Vector Laboratories Ltd, 
Peterborough, United Kingdom). They were then held in 
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place using a small coat of nail varnish around the edge and 
stored in a refrigerator.
Dynasore inhibition of nanoparticle 
uptake
The following day after attachment to glass coverslips, 
cells were rinsed twice with warm DMEM and incubated 
with 2 mL per well of DMEM and a 0.1% dilution of 
dynasore (Sigma-Aldrich Corporation, St, Louis, MO) 
from 80 mM stock or 0.1% dilution of dimethyl sulfoxide 
(Sigma-Aldrich) from 5 µg/mL stock. After 15 minutes 
the media was removed and replaced with: 1 mL of either 
DMEM or DMEM with 10% fetal calf serum; 0.1% 
dilution of dynasore or dimethyl sulfoxide; and 1% red 
FluoSpheres, which were then incubated for 15 minutes. 
Cells were then rinsed with PBS, fixed, and imaged as   
below.
Nanoparticle uptake studies in dominant 
negative transfected cells
Cells were transfected with 4 µg of either green fluores-
cent protein (GFP; Clontech Laboratories Inc, Mountain 
View, CA), EH29-GFP (provided by Alexandre Benmerah, 
Institut Cochin, Paris, France), or Caveolin1(Y14F)-GFP 
(provided by Mark McNiven, Mayo Clinic, Rochester, MN) 
using Lipofectamine™ 2000 (Invitrogen) according to the 
manufacturer’s protocol. Nanoparticle uptake assays were 
conducted the following day with two 2 mL PBS rinses 
followed by a 15-minute incubation with DMEM, which 
was then removed. Cells were incubated with a 1% dilution 
(from stock 0.2 mg/mL) of 20 nm carboxylate-modified 
polystyrene red FluoSpheres in either 1 mL of DMEM or 
DMEM with 10% fetal calf serum media for 15 minutes 
and washed twice in 2 mL PBS. Coverslips were fixed as   
above.
Transferrin uptake experiments
Cells were attached onto glass coverslips and incubated 
overnight. For the 4°C experiment, cells were put on ice for 
10 minutes in either serum-containing or serum-free media. 
Chilled transferrin (Alexa Fluor 488-labeled; Invitrogen) 
diluted to 0.2% in serum-free media were introduced to the 
cells for 15 minutes. For fixation, cells were rinsed in 2 mL 
chilled PBS twice and fixed with 2 mL 4% paraformalde-
hyde for 5 minutes. Chilled cells were then brought back to 
room temperature. They were then rinsed twice more with 
2 mL PBS and then placed cells down on a coverslip with 
a small drop of Vectashield containing 4′,6-diamidino-2-
phenylindole. They were then held in place using a small 
coat of nail varnish around the edge and stored in a   
refrigerator.
Sytox® Green (Invitrogen)
The Sytox Green for the nanoparticle and control conditions 
was in serum-free or serum-containing media during incu-
bation at a concentration of 0.02%. Alternatively, the fixed 
cells were incubated for 5 minutes in 0.1% Triton X100 solu-
tion (Sigma–Aldrich Corporation, St Louis, MO) and then 
incubated for 5 minutes in a 0.02% Sytox Green solution 
(Invitrogen, Grand Island, NY) before mounting.
Imaging and image analysis
Images for the comparison of nanoparticle effects at 4°C and 
37°C were taken on an A1R inverted confocal microscope 
(Nikon Corporation, Tokyo, Japan) using a 60 × oil immersed 
objective. All other images were taken using an LSM 710 
confocal microscope (Carl Zeiss Microscopy GmbH, 
Oberkochen, Germany) using 488 nm and 543 nm lasers with 
a 40 × or 60 × oil objective lens. All analyses were conducted 
using NIS-Elements 3.2 imaging software (Nikon). A cell that 
wasn’t in contact with any others was selected, and an image 
from the center of the confocal Z-stack was chosen. Total 
intensity of fluorescence per nanoparticle spot (defined as 
the visible intracellular accumulations of nanoparticles) was 
calculated by drawing around each spot and taking intensity 
values for it. The intracellular background fluorescence was 
subtracted (calculated from an area adjacent to the spot, of 
equal size). The number of nanoparticle spots per cell area 
was calculated by counting the number of visible nanoparticle 
spots in the slice chosen, and dividing it by the area of the cell 
in that slice. Any spots that lay on the cell membrane were 
not counted. Each experiment was performed three times, 
and from each experiment ten cells were analyzed.
Results
Serum effects
Previous studies have demonstrated a role for endocytosis 
pathways in the cellular entry of polystyrene nanoparticles.5–9 
Cells are conventionally cultured in the presence of 10% 
fetal calf serum; however, most assays for receptor-mediated 
endocytosis are performed in serum-free conditions.13–15 
  Furthermore, it has been previously suggested that the 
formation of a protein corona around nanoparticles might 
reduce membrane adsorption,10,16 and that interaction with the 
membrane may be important in permitting cellular entry.12,17 
Therefore, the potential for serum-dependent   cellular 
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Figure 1 The addition of serum to cells incubated with nanoparticles results in up to a 20-fold decrease in associated cellular fluorescence and a three-fold decrease in zeta 
potential, without affecting nanoparticle accumulation size compared to those incubated without serum. (A and B) Nanoparticle fluorescence signal associated with HeLa 
cells incubated with nanoparticles in either serum-free or serum-containing media over the course of 120 minutes. (C) Nanoparticle fluorescence signal associated with 
MDCK cells incubated with nanoparticles in either serum-free or serum-containing media after 60 minutes. (D) Zeta potential associated with nanoparticles in either serum-
free or serum-containing media. (E) Average nanoparticle hydrodynamic diameter (Z-average size) in either serum-free or serum-containing media. 
Abbreviation: SFM, serum-free media.
interactions of a well-characterized type of nanoparticle 
(20 nm carboxylate-modified polystyrene beads), which are 
commercially available with a variety of fluorescent tags, 
was evaluated.
HeLa human carcinoma cells were incubated with nano-
particles in the presence or absence of serum. As depicted in 
Figure 1, analysis of cellular-associated nanoparticle signal 
in a fluorescence plate reader demonstrated striking serum 
dependence. In both the presence and absence of serum, a 
time-dependent cellular nanoparticle signal was observed. 
However, at each time point evaluated the addition of serum 
resulted in an up to 20-fold decrease in cellular-associated 
nanoparticle signal. Similar effects were observed with 
MDCK canine epithelial cells (Figure 1C), suggesting that 
this effect is neither cell type nor species dependent.
One possible explanation for the observed serum depen-
dence in cellular association of nanoparticles would be that 
the serum proteins are causing the nanoparticles to aggregate, 
which might prevent cellular binding and/or entry. However, 
previously published dynamic light scattering data demon-
strate that serum does not cause aggregation of carboxylate-
modified polystyrene nanoparticles.18 Furthermore, this was 
verified in the dynamic light scattering measurements of the 
current study (Figure 1E). Another possible explanation for 
the observed effects could be due to serum directly reducing 
the fluorescence of the nanoparticles. However, time-lapse 
confocal microscopy demonstrates that the addition of serum 
to nanoparticles incubated in the absence of cells did not 
affect nanoparticle fluorescence (Figure 2). The particles 
depicted within a single field were individually quanti-
fied over time and no overall decrease in fluorescence was 
observed. Thus, it can be concluded that serum is directly 
reducing the potential of nanoparticles to interact with cells, 
rather than the fluorescence of the nanoparticles. One pos-
sible explanation for this can be the serum effects on the 
zeta potential of the nanoparticles (Figure 1D). The reduced 
negative charge may be a major contributing factor in the 
ability of nanoparticles to bind to the cell membrane.
One limitation of assays performed in a fluorescence plate 
reader is that it cannot readily distinguish between fluores-
cence associated with the cell surface and intracellular signal. 
  Therefore, to further analyze the effects of serum upon the 
interactions of nanoparticles with cells, confocal microscopy 
studies were performed. As depicted in Figure 3, when imaged 
with identical laser power and gain settings, both the cell sur-
face binding and the intracellular accumulation of nanoparticles 
was clearly higher in cells incubated in serum-free media when 
compared to cells exposed to nanoparticles in the presence 
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of 10% serum. Quantification of the brightness of numerous 
intracellular nanoparticle accumulations reveals significantly 
higher fluorescence in the serum-free group compared to the 
serum group (Figure 3C). The higher fluorescence seen on the 
cell membrane can also be seen (Figure 3E). It should be noted 
that the blue 4′,6-diamidino-2-phenylindole channel gain and 
exposure times were adjusted to facilitate the identification of 
cells, hence the discrepancy in appearance.
Although the precise intracellular compartment(s) within 
which the nanoparticles are present is not currently known, 
the apparent size and brightness is potentially consistent with 
endosomal localization. Furthermore, when compared with 
the nanoparticles imaged in vitro (Figure 2), it is clear that the 
intracellular nanoparticle accumulations are much larger than 
the potentially monodisperse population adhered to the cover-
slip. Interestingly, it can also be seen from these images that 
accumulation of nanoparticles in the nucleus was not observed. 
Finally, the number of intracellular nanoparticle accumulations 
per unit area was no different between the two conditions 
(Figure 3D), suggesting that although the total amount of nano-
particles able to enter cells is lower in the presence of serum, 
in both the presence and absence of serum the nanoparticles 
might be entering cells via the same pathway(s).
A cytotoxicity assay was performed to evaluate whether 
increased cell surface binding of nanoparticles has more 
of a detrimental effect on cells. As seen in Figure 4, cells 
exposed to these polystyrene nanoparticles display a moder-
ate degree of cytotoxicity. An approximately 30% decrease in 
cell numbers was observed relative to control at both 24 and 
72 hours following nanoparticle treatment, both when serum 
was present and absent at the time of exposure. However, due 
to internal variance and the modest effect observed, this was 
only statistically significant in the 24-hour serum-free and 
72-hour serum-containing conditions.
Endocytosis studies
Different pathways have been implicated in the cellular 
entry of nanoparticles depending upon the particular cell 
line used and/or the physiochemical characteristics of the 
specific particles being tested (eg, size, composition, or sur-
C 180
160
0
20
40
60
80
100
120
140
Pre-serum
15 min
25 min
5 min
30 min
20 min
10 min
F
l
u
o
r
e
s
c
e
n
c
e
 
i
n
t
e
n
s
i
t
y
AB  
2 µm 2 µm
30 minutes post-serum Pre-serum
Figure 2 The addition of serum to nanoparticles in the absence of cells does 
not  affect  nanoparticle  fluorescence.  Representative  images  of  nanoparticles  in 
(A) serum-free media and (B) after 30 minutes incubation with serum. (C) Total 
fluorescence intensity of nanoparticle spots in a single frame over 30 minutes.
Distance along line for SFM data (µm)
N
P
 
f
l
u
o
r
e
s
c
e
n
c
e
900
600
300
2 0
0
8 46 10
SFM
SFM
Serum
Serum SFM Serum
E
C D
0
2000
4000
8000
6000
0.04
0.03
0.02
0.01
0.00
A
v
e
r
a
g
e
 
N
P
 
s
p
o
t
f
l
u
o
r
e
s
c
e
n
c
e
A
v
e
r
a
g
e
 
N
P
 
s
p
o
t
p
e
r
 
µ
m
2
 
p
e
r
 
c
e
l
l
P-value > 0.05
P-value < 0.05
A B Serum 10 µm
10 µm
SFM
Figure 3 Both cell surface binding and intracellular accumulation of nanoparticles 
is higher in cells incubated in serum-free media. Representative images of a HeLa 
cell incubated with nanoparticles in (A) serum-free media and (B) serum-containing 
media. (C) Average nanoparticle spot fluorescence for cells incubated in serum-free 
or serum-containing media. There is a significant decrease in fluorescence for cells 
incubated in serum. (D) Average spot density for cells incubated in serum-free or 
serum-containing media. There is no difference between the two. (E) Line scan 
profiles of the cell membrane demonstrate greatly increased cell surface nanoparticle 
binding in serum-free media relative to serum-containing media. 
Abbreviations: NP, nanoparticle; SFM, serum-free media.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2049
Cellular entry of nanoparticlesInternational Journal of Nanomedicine 2012:7
A
C
SFM
00
0
20
40
60
80
100
120
140
160
10
20
30
40
50
60
70
0
50
100
200
150
10
20
30
40
50
60
72 h SFM
24 h SFM 24 h Serum
72 h Serum
SFM + np SCM SCM + np
SCM SCM + np SFM SFM + np
B
D
N
u
m
b
e
r
 
o
f
 
c
e
l
l
s
 
(
x
1
0
4
)
 
p
e
r
 
m
L
N
u
m
b
e
r
 
o
f
 
c
e
l
l
s
 
(
x
1
0
4
)
 
p
e
r
 
m
L
N
u
m
b
e
r
 
o
f
 
c
e
l
l
s
 
(
x
1
0
4
)
 
p
e
r
 
m
L
N
u
m
b
e
r
 
o
f
 
c
e
l
l
s
 
(
x
1
0
4
)
 
p
e
r
 
m
L
P-value < 0.05
Experiment 1
Experiment 2
Experiment 3
Experiment 4
Experiment 1
Experiment 2
Experiment 3
Experiment 4
Experiment 1
Experiment 2
Experiment 3
Experiment 4
Experiment 1
Experiment 2
Experiment 3
Experiment 4
P-value < 0.05
Figure 4 Nanoparticles have a minor cytotoxic effect on cells in both serum-containing and serum-free conditions. Graphs displaying the effects of incubating cells in 
(A and C) serum-free media with and without nanoparticles and (B and D) serum-containing media with and without nanoparticles. (A and B) Twenty-four hours and 
(C and D) 72 hours after a 15-minute incubation. 
Abbreviations: h, hours; np, nanoparticle; SCM, serum-containing media; SFM, serum-free media.
A           Control
A
v
e
r
a
g
e
 
N
P
 
s
p
o
t
 
f
l
u
o
r
e
s
c
e
n
c
e
A
v
e
r
a
g
e
 
s
p
o
t
 
p
e
r
 
µ
m
2
 
p
e
r
 
c
e
l
l CD
5 µm5  µm
B           Dynasore
Dynasore DMSO Dynasore DMSO
P-value < 0.05
0 0.000
0.005
0.010
0.015
0.020
500
1000
1500
2000
2500
3000 P-value < 0.05
Figure 5 In the absence of serum, dynasore treatment results in clear inhibition 
of nanoparticle entry. Representative images of (A) a HeLa cell incubated with 
nanoparticles in serum-free media and (B) a HeLa cell incubated with nanoparticles 
treated  with  dynasore  in  serum-free  media.  (C)  Average  nanoparticle  spot 
fluorescence and (D) average spot density for HeLa cells incubated with dynasore 
or dimethyl sulfoxide (control) with nanoparticles in serum-free media. 
Abbreviations: DMSO, dimethyl sulfoxide; NP, nanoparticle.
face characteristics).4–8 Therefore, the aim was to empirically 
determine which endocytosis pathway(s) might be involved 
in entry of 20 nm   carboxylate-modified polystyrene beads 
in HeLa cells. Dynamin is a large guanosine triphosphatase 
which regulates several endocytosis pathways and is potently 
and specifically inhibited by the small molecule dynasore.19,20 
As depicted in Figure 5, in the absence of serum, dynasore 
treatment results in a clear inhibition of nanoparticle entry. 
Results from studies in the presence of serum have been 
omitted as previous studies have shown that serum inhibits 
dynasore function.21
Two main endocytosis pathways regulated by 
dynamin are clathrin-mediated endocytosis and caveolar 
  endocytosis.19 Therefore, one intention of this work was 
to determine whether each of these might be involved in 
nanoparticle entry. Importantly, the authors have extensive 
experience with these inhibitors in endocytosis assays, and 
have previously shown positive controls for each.13–15,22–24 
As observed in Figure 6, expression of the inhibitor of 
clathrin-mediated endocytosis eps15(EH29),25 but not 
dominant negative caveolin1,26 significantly reduced 
nanoparticle uptake. In cells exposed to nanoparticles in 
serum free media following transfection with either GFP, 
as control, EH29, to inhibit clathrin-mediated endocytosis, 
or caveolin1(Y14F), to inhibit caveolar endocytosis, only 
EH29 inhibited nanoparticle entry. Quantification revealed 
that both the brightness and density of intracellular nano-
particle accumulations were significantly inhibited by 
expression of EH29.
Similar observations were obtained in cells expressing 
these constructs and incubated with nanoparticles in the 
presence of serum (Figure 7). Interestingly though, although 
the expression of EH29 significantly reduced the number of 
nanoparticle accumulations per cell, relative to the control, 
while decreased quantitatively, the nanoparticle spot fluores-
cence was not significantly different (P value = 0.058). How-
ever, expression of caveolin1(Y14F) actually increased the 
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fluorescence of the intracellular nanoparticle accumulations 
relative to the control in this study. Therefore, it is possible 
that inhibiting caveolar endocytosis increases nanoparticle 
entry, possibly through a similar mechanism as was recently 
observed in cells taking up fluorescent dextran.27 In this study, 
expression of this same mutant increased uptake of 70 kDa 
dextran in ARPE-19 cells. Thus, taken together, these results 
demonstrate that both in the presence and absence of serum, 
nanoparticles can enter cells through dynamin-dependent/
clathrin-mediated endocytosis, and that in this system caveolar 
endocytosis does not seem to be directly involved in nano-
particle entry.
Nanoparticle-mediated cellular 
permeabilization
As depicted in Figures 5–7, inhibition of   dynamin-  dependent/
clathrin-mediated endocytosis significantly, but not 
  completely, inhibited nanoparticle entry into cells. The 
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proportion of nanoparticle internalization resistant to inhibi-
tion of endocytosis could be due to an incomplete inhibition 
of endocytosis, or it could be that nanoparticles are entering 
cells through another mechanism. An alternative method for 
inhibiting endocytosis is to cool cells to 4°C,28 and, as can be 
seen in Figure 8, at 4°C nanoparticles are still able to gain 
entry into the cytosol. Importantly, these same conditions 
resulted in a nearly complete inhibition of the internalization 
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of transferrin, a cargo molecule known to be internalized 
through clathrin-mediated endocytosis13–15 (Figure 9). This 
might suggest that an endocytosis-  independent route for 
nanoparticle entry exists, particularly when considering 
that the presence of serum during nanoparticle incuba-
tion at 4°C does not inhibit entry; in fact, the intracellular 
density of nanoparticle accumulations was slightly higher 
compared to cells kept in serum-free media. Given the size 
and negative charge of the nanoparticles being studied, it 
is not likely that nanoparticles are able to freely diffuse 
across the plasma membrane. However, it might be that 
nanoparticles are   entering through   discontinuities in the 
plasma membrane, either preexisting or induced by the 
nanoparticles through direct permeabilization of the cell   
surface.
Sytox Green is a commercially available reagent that is 
membrane impermeant and brightly fluorescent only fol-
lowing binding to nucleic acids.29 Therefore, Sytox Green 
can be used to measure the potential for plasma membrane 
permeabilization. As depicted in Figure 10, incubation of 
cells in the presence of nanoparticles at 4°C in serum-free 
and serum-containing media resulted in significantly higher 
Sytox Green fluorescence than control cells. Strikingly, the 
extent of Sytox Green fluorescence was roughly equivalent 
to that observed in cells incubated in the presence of 0.1% 
Triton X100, a detergent which is commonly employed to 
permeabilize the plasma membrane. Thus, these results 
demonstrate that incubation of cells with 20 nm carboxylate-
modified polystyrene nanoparticles can result in disruption 
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of the plasma membrane, and suggest that this might be 
responsible for a significant proportion of nanoparticle 
entry in cells.
Discussion
The increased potential for human exposure to manufac-
tured nanomaterials emphasizes the need for a greater 
understanding of cellular nanotoxicology. In many cases, 
particular nanoparticles and target cell types will need to be 
empirically investigated as varying cell types react in distinct 
ways to the introduction of nanoparticles,9 which themselves 
display unique behaviors in biological fluid.30 However, the 
use of well-characterized model nanoparticles with known 
properties is necessary to provide insight into potentially 
biomedically relevant phenomena. In this study, a detailed 
analysis of the route of entry for 20 nm carboxylate-modified 
polystyrene nanoparticles was performed. The results of the 
analyses provide exciting new observations which open up 
new perspectives in the field of cellular nanotoxicology, and 
suggest several mechanisms relevant to nanoparticle entry 
that should be considered in future studies.
The first series of experiments consider the potential 
effects of serum on nanoparticle entry into cultured cells. 
With a fluorescence plate reader, a striking reduction in 
cellular-associated nanoparticle signal was observed when 
cells were incubated with nanoparticles in serum-  containing, 
  versus serum-free, conditions. Furthermore, this was observed 
with cells from different organisms, and in both epithelial 
and transformed cells. A more detailed analysis through 
confocal microscopy revealed that the presence of serum 
both reduced nanoparticle signal at the plasma membrane 
and intracellular accumulation. Therefore, serum appears to 
be able to reduce the ability of nanoparticles to bind to and 
enter cells, observations previously alluded to with the use of 
larger (eg, ∼64 nm) positively-charged nanoparticles.10
Next, several potential mechanisms for nanoparticle 
internalization into cells were evaluated. In both serum-free 
and   serum-containing studies, it was demonstrated that these 
nanoparticles can enter cells through dynamin-dependent/ 
clathrin-mediated endocytosis, and not caveolar endocytosis. 
However, the presence of endocytosis-independent nanopar-
ticle uptake was also able to be demonstrated. The analyses 
demonstrate that 20 nm carboxylate-modified polystyrene 
nanoparticles have the capacity to induce plasma membrane 
  permeabilization. Therefore, this may reflect an   alternative means 
by which nanoparticles are able to gain entry to the intracellular 
space, and potentially cause cellular damage.
In the current study, it was demonstrated that nano-
particle interaction with, and subsequent entry into cells, 
is significantly inhibited by the presence of serum. It has 
been noted that a highly fluidic protein corona with a rapid 
exchange rate is less likely to adsorb to the plasma mem-
brane,16 possibly due to the resulting reduced zeta potential. 
Furthermore, carboxy functionalization of nanoparticles has 
been proposed to be more amiable to nanoparticle–protein 
interactions than amino modifications.11 Finally, the relation-
ship between decreased membrane adsorption and reduced 
uptake of nanoparticles has been previously suggested.10,17 
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Taken together, this suggests that the addition of serum gen-
erates a highly fluidic protein corona with a rapid exchange 
rate which prevents absorption to the plasma membrane and 
subsequent internalization.
In order to quantitatively assess the relative potential for 
nanoparticle entry through the fluid phase, dispersed in the 
lumen of a vesicle, as opposed to through receptor-mediated 
means, adhered to the inner membrane of the vesicle, a series 
of calculations was performed to estimate the number of 
nanoparticles that could enter a vesicle under the incubation 
conditions described above (Figure 11). This analysis assumed 
a total vesicle diameter of 150 nm,31 and that the entire cell 
surface has the capacity to be coated in nanoparticles. Even 
though the latter might be an overestimation, the current 
analyses suggest that under these conditions nanoparticles are 
nearly 25,000 times more likely to enter cells bound to the inner 
membrane of a vesicle than through the fluid phase. Thus, when 
taken together, the data suggest that cellular entry of 20 nm 
carboxylate-modified polystyrene nanoparticles is reduced 
in the presence of serum primarily through inhibition of cell 
surface binding, that clathrin-mediated endocytosis represents 
a significant route for nanoparticle uptake, and that these nano-
particles potentially have the capacity to enter the cell directly 
through permeabilization of the plasma membrane.
Conclusion
In summary, the current report analyzes the cellular inter-
nalization of model nanoparticles, focusing on factors which 
might affect the association of nanoparticles with cells and 
possible routes of entry into cells. It has been established that 
the presence of serum in media greatly decreases cellular 
nanoparticle fluorescence intensity. This was shown to be 
neither cell type nor species dependent. Furthermore, it was 
shown that nanoparticle entry into cells was greatly reduced 
when inhibiting the dynamin-dependent/clathrin-mediated 
endocytosis pathway. Finally, using a membrane impermeant 
nucleic acid stain, it was shown that the presence of nano-
particles permeabilizes the plasma membrane to a similar 
extent as a detergent, Triton X100. This would suggest that 
permeabilization of the plasma membrane may be responsible 
for a proportion of nanoparticle entry into cells.
Executive summary
•	 Cells were incubated with 20 nm carboxylate-modified 
polystyrene nanoparticles in the presence of serum-
containing and serum-free media.
•	 Serum-containing media was found to decrease intra-
cellular nanoparticle accumulation, primarily through 
inhibition of cell surface binding.
•	 Clathrin-mediated endocytosis represents a significant 
route for nanoparticle uptake.
•	 These nanoparticles potentially have the capacity to 
enter the cell directly through permeabilization of the 
cell membrane.
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